最新ニュース SWK Holdings (NASDAQ:SWKH) 株価情報

SWK Holdings

SWK Holdings Corp is a healthcare capital provider. The company offers financing solutions to various life science companies, institutions, and inventors. It involves monetizing cash flow streams derived from commercial-stage products and related intellectual property through royalty purchases and financings, as well as through the creation of synthetic revenue interests in commercialized products. Through its wholly-owned subsidiary, it also provides non-discretionary investment advisory services to institutional clients. The company's operating segments are Finance Receivables and Pharmaceutical Development Services. It generates maximum revenue from the Finance Receivables segment.

SWK Holdings Corp

SWK Holdings Corporation - 9.00% Senior Notes due 2027

SWK Holdings: Baby Bond Represents Only Debt And 8.9% Coupon Yield

SWK Holdings gives portfolio update

SWK Holdings Non-GAAP EPS of $0.33, revenue of $10.42M

SWK Holdings ( ($SWKH) ) has provided an announcement. The Company has published an investor presentation showcasing their use of Non-GAAP Financia...

SWK Holdings Highlights Financial Strategy in Presentation

SWK Holdings Corporation ( ($SWKH) ) has released its Q3 earnings. Here is a breakdown of the information SWK Holdings Corporation presented to its...

SWK Holdings Reports Increased Revenues Amidst Challenges

Analyst Michael Diana of Maxim Group maintained a Buy rating on SWK Holdings (SWKH – Research Report), with a price target of $22.00. Michael Diana...

SWK Holdings: Anticipated Growth in Q4 2024 Drives Buy Rating with 37% Upside Potential

Originations: In November, SWK advanced $5.0M to existing borrower Journey Medical to help fund the company's launch of Emrosi. In November, as par...

SWK Holdings provides portfolio update

SWK Holdings: Baby Bond Yielding 8.8% A Good Choice For Income Investors

Biodexa Pharmaceuticals (BDRX) announced the appointment of Dr Gary Shangold as Chief Medical Officer with immediate effect. Most recently, Shangol...

Biodexa Pharmaceuticals appoints Shangold as Chief Medical Officer

Biodexa appoints Gary A. Shangold as Chief Medical Officer

BDRX

SWKH

SWKHL

Earnings

Press Releases

SWK Holdings Corporation Announces Financial Results for Fourth Quarter 2023

SWK Holdings Corporation Announces Financial Results for First Quarter 2024

Management

SWK Holdings Appoints Chief Financial Officer

News

SWK Holdings Highlights Recent Achievements and Provides Portfolio Update

SWK Holdings Corporation Announces Financial Results for Second Quarter 2024

SWK Holdings Provides Portfolio Update

SWK Holdings Corporation Announces Financial Results for Third Quarter 2024

Biodexa Strengthens Management Team - Appointment of Dr Gary A. Shangold as Chief Medical Officer

BIOL

BTCY

DERM

ELUT

ETON

Acacia Research Corporation - Common Stock

Acacia Research

Eason Technology Limited American Depositary Shares (each representing sixty-thousand (60,000) Ordinary Shares)

Comments

SWK Holdings

ニュース

最新ニュース SWK Holdings (NASDAQ:SWKH) 株価情報

こんな人も見ています

ニュース

パートナーシップ

ベンジンガ・グローバル